These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6860359)

  • 1. S-adenosylhomocysteine hydrolase activity, deoxyadenosine triphosphate accumulation, and competence of thymocyte and spleen leucocyte response to mitogens in coformycin-treated mice.
    Lukey T; Snyder FF
    Biochem Pharmacol; 1983 Apr; 32(8):1399-406. PubMed ID: 6860359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice.
    Helland S; Ueland PM
    Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM; Henderson JF
    Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
    Ratech H; Thorbecke GJ; Hirschhorn R
    Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
    Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W
    Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
    Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
    Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biochemical and clinical consequences of 2'-deoxycoformycin in T cell chronic lymphocytic leukaemia.
    Hallam LJ; Van der Weyden MB; Ackland SP; Bagnara AS; Whiteside MG
    Scand J Haematol; 1984 Jan; 32(1):55-64. PubMed ID: 6607510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
    Hershfield MS; Kredich NM
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of purine metabolism in lymphocytes.
    Henderson JF; Smith CM; Zombor G
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):419-26. PubMed ID: 3875099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
    Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
    Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine metabolizing enzymes of lymphocyte cell populations: correlation between AMP-deaminase activity and dATP accumulation in murine lymphocytes.
    Dornand J; Clofent G; Bonnafous JC; Favero J; Mani JC
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):448-55. PubMed ID: 2991938
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicity and immunosuppressive activity of binary combinations of 2'-deoxycoformycin and 2'-deoxyadenosine.
    Paine RM; Weston BJ; Clink HM; Kohn J; Neville AM; McGhee KG; Harrap KR
    Cancer Treat Rep; 1981; 65(3-4):259-66. PubMed ID: 6972254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
    Begleiter A; Pugh L; Israels LG; Johnston JB
    Cancer Res; 1988 Jul; 48(14):3981-6. PubMed ID: 3260129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation.
    Van De Wiele CJ; Vaughn JG; Blackburn MR; Ledent CA; Jacobson M; Jiang H; Thompson LF
    J Clin Invest; 2002 Aug; 110(3):395-402. PubMed ID: 12163459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific immunosuppressive effects of constant infusion of 2'-deoxycoformycin.
    Trotta PP; Tedde A; Ikehara S; Pahwa R; Good RA; Balis ME
    Cancer Res; 1981 Jun; 41(6):2189-96. PubMed ID: 6972248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients.
    Hirschhorn R; Roegner-Maniscalco V; Kuritsky L; Rosen FS
    J Clin Invest; 1981 Dec; 68(6):1387-93. PubMed ID: 7033281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.